July/August 2017

Feature

Multidisciplinary Management of Multiple Myeloma in Older Adults

08/17/2017

Nader Tavakoli, MD, CMD, FAAFP

Sidrah Khan, MD

Shelby Knowles, MD

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD

Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...

...

08/17/2017

Journal of Clinical Pathways

Pathways in Focus

Applying First Principles Thinking to Cancer Care Delivery

08/16/2017

Aymen Elfiky, MD, MSc, MBA—Column Editor

A first principle is a basic, foundational, self-evident proposition or assumption that cannot be deduced from any other proposition or assumption. The concept of first principles thinking has been advocated by...

A...

08/16/2017

Journal of Clinical Pathways

Insights

Interview

The Role of Value in the Health Care Economy

08/17/2017

JCP Editors

The term “value-based care” frequently comes up in discussions of clinical pathways and standards of care. But what does it actually mean? And who gets to define value, and for what patient population? Many parties...

The...

08/17/2017

Journal of Clinical Pathways

Department

Research in Review

Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine

08/17/2017

JCP Editors

Blood Test Predicts Survival Outcomes in Patients With Lung Cancer A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell...

Blood...

08/17/2017

Journal of Clinical Pathways

Conference Preview

A Preview of the Clinical Pathways Congress

08/16/2017

JCP Editors

In September 2016, Journal of Clinical Pathways (JCP) launched Clinical Pathways Congress, its official meeting. The weekend-long event attracted key opinion leaders from all aspects of clinical pathway development...

In...

08/16/2017

Journal of Clinical Pathways

Feature

Perspectives

Pharmaceutical Manufacturer Responses to Health Care Professional and Clinical Pathway Developer Requests for Medical Information

08/16/2017

AnnaMaria D’Ascoli, BS, PharmD, MBA

JR Meloro, BA

Teresa McShane, PhD, DVM

Abstract: Oncology is one of the most complex and rapidly changing fields in medicine. Both practicing health care professionals (HCPs) and developers of clinical pathways require information about the latest...

...

08/16/2017

Journal of Clinical Pathways

Column

Clinical Pathways GPS

Truly Patient-Centered Clinical Pathways

08/16/2017

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Scott Guerin, PhD

For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...

For...

08/16/2017

Journal of Clinical Pathways

Editor's Page

A Moment in the Spotlight for Clinical Pathways

08/16/2017

Winston Wong, PharmD, Editor-in-Chief

Summer is a time of rest and relaxation, when we recharge our batteries in order to gain the energy needed to propel us through the rest of the year. That’s especially true here at Journal of Clinical Pathways (JCP),...

Summer...

08/16/2017

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

July/August 2017

Insights

Department

Feature

Column

Current Issue

Special Reports

Subscribe

Volume 3

Specialties

Events

Year Round Education

HMP Global Products